№ files_lp_4_process_1_47475
File format: docx Character count: 3061 File size: 23 KB
Step-by-step procedural guide for implementing and analyzing a P-Graph model to optimize the collection, processing, and recycling of plastic waste, based on a specific case study.
Year: 2026
Region / City: Not specified
Subject: Supply chain optimization for plastic waste management
Document Type: Instruction manual / Case study guide
Institution / Organization: Not specified
Author: Not specified
Target Audience: Researchers, engineers, and analysts in waste management and recycling
Effective Period: Upon publication
Reference Manuscript: Designing Cost-Effective Supply Chains for Plastics at the End-of-Life
Software Mentioned: P-Graph Studio
Data Requirements: Excel file with units, operations, and distances
Cost Analysis Included: CAPEX and OPEX assessment
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
A simpler, more cost-effective fill optionEPS geofoam benefits and costs compared to traditional fills
Year: 2023
Region / City: Seattle-Tacoma, Gary, Renton
Subject: Civil engineering, Public works, Construction materials
Document Type: Article
Organization / Institution: N/A
Author: Nico Sutmoller
Target Audience: Construction professionals, engineers, public works agencies
Effective Date: N/A
Date of Approval: N/A
Date of Changes: N/A
Quality by Design Based Pharmaceutical Development Report of Cost-Effective Dexamethasone Tablets 20 mg for Regulatory Submission
Year: Not specified
Region / Market context: United States, European Union, India
Field: Pharmaceutical development
Document type: Pharmaceutical development report
Drug product: Dexamethasone Tablets 20 mg
Therapeutic area: Oncology and anti-inflammatory therapy
Indication mentioned: Multiple myeloma adjunct therapy
Development approach: Quality by Design (QbD)
Reference product: HEMADY™ (Dexamethasone) Tablets 20 mg
Reference product manufacturer: Dexcel Pharma Technologies Ltd, Israel
Reference product distributor: Acrotech Biopharma Inc, USA
Active pharmaceutical ingredient: Dexamethasone (micronized API)
Key excipients: Lactose Monohydrate, Corn Starch, Povidone, Sodium Starch Glycollate Type A, Magnesium Stearate
Manufacturing process: Direct blending and compression
Critical Material Attribute (CMA): API particle size distribution below 10 microns
Critical Process Parameter (CPP): Blending time (15 minutes pre-lubrication, 5 minutes lubrication)
Critical Quality Attributes (CQA): Blend flow, hardness, dissolution
Stability testing conditions: 40°C ± 2°C / 75% RH ± 5% RH for 6 months
Packaging evaluated: Bottle and blister pack
Regulatory framework referenced: ICH Q8 (R2), ICH stability guidelines
Supporting regulatory sources: US DMF, CEP, USP, BP, Ph.Eur
Related patent referenced: US10,537,585 B2 (21 January 2020)
Primary objective: Development of a cost-effective bioequivalent dexamethasone tablet formulation
End-of-Life Care Coordinator (1.0 WTE)
Year: 2020
Region / city: Galway, Ireland
Subject: End-of-life care
Document Type: Job Specification
Organization: Saolta University Health Care Group
Author: Saolta University Health Care Group
Target Audience: Healthcare professionals, candidates for the position
Period of Validity: Permanent, as per job offer
Approval Date: N/A
Date of Changes: N/A
House Resolution to Recognize and Congratulate Colt Shope, a Nurse Manager at Prisma Health Baptist Easley Hospital, for Introducing Baptist Easley’s New Tradition to Honor American Veterans in End-of-Life Care
Year: 2025
Region / City: South Carolina
Document Type: Resolution
Organization / Institution: South Carolina House of Representatives
Author: South Carolina House of Representatives
Target Audience: Healthcare professionals, Veterans, General public
Effective Period: February 2025
Approval Date: February 2025
Date of Changes: N/A
CPUC AND CALRECYCLE HOST WORKSHOP Addressing End-of-life Management for Photovoltaic Panels and Batteries for Electric Vehicles and Energy Storage
Year: 2019
Region / City: San Francisco
Topic: End-of-life management, recycling, photovoltaic panels, electric vehicle batteries
Document Type: Media Advisory
Organization: California Public Utilities Commission (CPUC), California Department of Resources Recycling and Recovery (CalRecycle)
Author: Not specified
Target Audience: General public, environmental stakeholders, industry professionals
Event Date: April 3, 2019
Approval Date: March 28, 2019
Date of Changes: Not specified
End-of-life care in Medway: Identifying Needs and Improving Services
Year: 2016
Region / City: Medway
Topic: End-of-life care, palliative care
Document Type: Report
Organization: Medway CCG
Author: National End-of-Life Care Strategy
Target Audience: Health professionals, policymakers, care providers
Period of Validity: 2016-2020
Date of Approval: N/A
Date of Changes: N/A
Minutes of the Meeting of the Expert Group on Waste Directive 2000/53/EC on End-of-Life Vehicles (ELV)
Date: 14 February 2017
Location: Brussels
Subject: Waste Directive 2000/53/EC on End-of-Life Vehicles (ELV)
Type of Document: Meeting Minutes
Organ / Institution: European Commission
Author: Expert Group on Waste Directive 2000/53/EC
Target Audience: European Commission Experts, Stakeholders
Period of Effectiveness: November 2016 – August 2017
Approval Date: 14 February 2017
Date of Last Update: 21 January 2017
Topics: P-Graph Cost-Effective End-of-Life